RWA
ABMD

River Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

River Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$33K – 538
2018
Q4 		$33K Hold
100
– – 0.01% 290
2018
Q3 		$45K Hold
100
– – 0.02% 286
2018
Q2 		$41K Buy
+100
New +$36.2K 0.02% 291

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

River Wealth Advisors's ABMD Position: Q1 2019 in Review

River Wealth Advisors sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 100 shares — an estimated $33K sold.

River Wealth Advisors first reported a position in ABMD in Q2 2018 and held it in 3 quarters. The position peaked at $45K in Q3 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • River Wealth Advisors reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • River Wealth Advisors sold 100 Abiomed Inc shares in Q1 2019, an estimated $33K.
  • River Wealth Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 3 quarters.
  • River Wealth Advisors's Abiomed Inc position peaked at $45K in Q3 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on River Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.